SCHEMBL24216388

SCHEMBL24216388

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc5c(c4)CNC5)nn3)cc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 9/20 0.57
▸ GSK3B P49841 4/20 0.41
▸ ROCK2 O75116 3/20 0.41
▸ CDC7 O00311 2/20 0.41
▸ ESRRG P62508 1/20 0.41
▸ KDR P35968 3/20 0.39
▸ PIM1 P11309 2/20 0.39
▸ AURKB Q96GD4 2/20 0.39
▸ TEK Q02763 3/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ PLK4 O00444 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ CHUK O15111 1/20 0.38
▸ MAPK13 O15264 1/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ FGFR1 P11362 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30409126 1.00 HDAC6 (0.57) HDAC6GSK3BROCK2CDC7ESRRG
SCHEMBL30410493 0.87 HDAC6 (0.52) HDAC6HDAC1
SCHEMBL30408037 0.87 HDAC6 (0.44) HDAC6GSK3BROCK2PIM1AURKB
SCHEMBL24216903 0.87 HDAC6 (0.52) HDAC6HDAC1
SCHEMBL24216015 0.87 HDAC6 (0.44) HDAC6GSK3BROCK2PIM1AURKB
SCHEMBL24216855 0.85 HDAC6 (0.54) HDAC6GSK3BROCK2CDC7ESRRG
SCHEMBL30408941 0.85 HDAC6 (0.54) HDAC6GSK3BROCK2CDC7ESRRG
SCHEMBL25267369 0.84 HDAC6 (0.53) HDAC6GSK3BROCK2CDC7ESRRG
SCHEMBL30425675 0.84 HDAC6 (0.53) HDAC6GSK3BROCK2CDC7ESRRG
SCHEMBL24216864 0.83 HDAC6 (0.52) HDAC6KDRTEKHDAC1EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
WO-2022013728-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2022-01-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885GSK3B 192/4885ROCK2 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback